Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Duquesne Family Office

Founders Stanley Druckenmiller

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$60M
Portfolio companies 5
Lead investments 2
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Therapeutics
  • Robotics
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Duquesne Family Office:
Typical Co-investors
Duquesne Family Office is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Duquesne Family Office:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Builders and Backers Capital District of Columbia, United States, Washington
Creation Venture Partners Chaoyang, China, Liaoning
D-Ax Corporate Venture Capital Stockholm, Stockholm County, Sweden
Dangdai Zhiye China, Hong Kong, Hong Kong Island
DFW Capital New Jersey, Teaneck, United States
Digital Irish Angels New York, New York, United States
Enbei Investment -
Georgia Venture Partners Atlanta, Georgia, United States
Hansae Seoul, Seoul-t'ukpyolsi, South Korea
Hongxin Ziben China, Fujian, Xiamen
Lionhart Advisors Group Canada, Ontario, Toronto
Mega Holding -
NeuroSpring California, Orinda, United States
PTC Therapeutics New Jersey, South Plainfield, United States
Seentao Technology Beijing, Beijing, China
Teleclal Group Israel, Tel Aviv, Tel Aviv District
The Catalyst Capital Group Canada, Ontario, Toronto
Venture Strategy Partners California, San Francisco, United States
Wire Accelerator -
ZHEXINIT China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arcana

Software
$5M01 May 2022 New York, New York, United States

VavaCars

Automotive
Internet
Sales
Transportation
$50M15 Oct 2021 Sisli, Istanbul, Turkey

C2i Genomics

Genetics
Health Care
Health Diagnostics
Therapeutics
Wellness
$100M15 Apr 2021 New York, New York, United States

Immunai

Artificial Intelligence
Biotechnology
Machine Learning
Therapeutics
$60M11 Feb 2021 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Duquesne Family Office?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 60M
Peak activity year 2021
Lead investments 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Arcana

Software
$5M01 May 2022 New York, New York, United States

VavaCars

Automotive
Internet
Sales
Transportation
$50M15 Oct 2021 Sisli, Istanbul, Turkey

C2i Genomics

Genetics
Health Care
Health Diagnostics
Therapeutics
Wellness
$100M15 Apr 2021 New York, New York, United States

Immunai

Artificial Intelligence
Biotechnology
Machine Learning
Therapeutics
$60M11 Feb 2021 New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: